Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001804220-23-000016
Filing Date
2023-05-04
Accepted
2023-05-04 07:14:54
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q regn-20230331.htm   iXBRL 10-Q 1981539
2 FIRST AMENDMENT TO CASH INCENTIVE BONUS PLAN regn-ex_101x3312023x10q.htm EX-10.1 6060
3 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) regn-ex_311x3312022x10q.htm EX-31.1 12100
4 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) regn-ex_312x3312022x10q.htm EX-31.2 12124
5 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 regn-ex_32x3312022x10q.htm EX-32 6919
  Complete submission text file 0001804220-23-000016.txt   7151159

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20230331.xsd EX-101.SCH 44689
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT regn-20230331_cal.xml EX-101.CAL 61780
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT regn-20230331_def.xml EX-101.DEF 262249
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20230331_lab.xml EX-101.LAB 468508
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20230331_pre.xml EX-101.PRE 338932
64 EXTRACTED XBRL INSTANCE DOCUMENT regn-20230331_htm.xml XML 1147546
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 23886439
SIC: 2834 Pharmaceutical Preparations